Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “THE UNITED STATES OF AMERICA, as represented by th”

2,147 pharma patents match "THE UNITED STATES OF AMERICA, as represented by th" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,147
Index total 30,257
Page 67 / 90

Quick answer

This filtered view shows 2,147 pharmaceutical patents matching "THE UNITED STATES OF AMERICA, as represented by th" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,147 results for “THE UNITED STATES OF AMERICA, as represented by th” · 30,257 patents in full index Clear search

  1. US 7517527

    Immunotoxin with in vivo T cell suppressant activity and methods of use

    The United States of America, as represented by the Department of Health and Human Services · Granted Apr 14, 2009 · Expires Apr 9, 2029

    granted

  2. US 7517849

    Inhibition of ABC transporters by transmembrane domain analogs

    The United States of America, as represented by the Secretary, Health and Human Services · Granted Apr 14, 2009 · Expires Apr 9, 2029

    granted

  3. US 7517531

    Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4

    The United States of America, as represented by the Department of Health and Human Services · Granted Apr 14, 2009 · Expires Apr 9, 2029

    granted

  4. US 7514529

    Peptide mimotopes of lipooligosaccharide from nontypeable Haemophilus influenzae as vaccines

    The United States of America, as represented by the Department of Health and Human Services · Granted Apr 7, 2009 · Expires Apr 2, 2029

    granted

  5. US 7514415

    Method of treating inflammatory arthropathies with suppressors of CpG oligonucleotides

    The United States of America, as represented by the Department of Health and Human Services · Granted Apr 7, 2009 · Expires Apr 2, 2029

    granted

  6. US 7514414

    Suppressors of CpG oligonucleotides and methods of use

    The United States of America, as represented by the Department of Health and Human Services · Granted Apr 7, 2009 · Expires Apr 2, 2029

    granted

  7. US 7511015

    Modified defensins and their use

    The United States of America, as represented by the Department of Health and Human Services · Granted Mar 31, 2009 · Expires Mar 26, 2029

    granted

  8. US 7511032

    Pyrrolobenzodiazepine derivatives, compositions comprising the same and methods related thereto

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 31, 2009 · Expires Mar 26, 2029

    granted

  9. US 7507538

    Human papilloma virus immunoreactive peptides

    The United States of America, as represented by the Department of Health and Human Services · Granted Mar 24, 2009 · Expires Mar 19, 2029

    granted

  10. US 7504430

    Maleiimide anti-tumor phosphatase inhibitors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 17, 2009 · Expires Mar 12, 2029

    granted

  11. US 7504243

    Methods for the production of biliverdin

    The United States of America, as represented by the Department of Health and Human Services · Granted Mar 17, 2009 · Expires Mar 12, 2029

    granted

  12. US 7501132

    Multiple antigenic peptides immunogenic against Streptococcus pneumonia

    The United States of America, as represented by the Department of Health and Human Services · Granted Mar 10, 2009 · Expires Mar 5, 2029

    granted

  13. US 7501501

    MHC-Class II restricted melanoma antigens and their use in therapeutic methods

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 10, 2009 · Expires Mar 5, 2029

    granted

  14. US 7498336

    Deazaflavin compounds and methods of use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 3, 2009 · Expires Feb 26, 2029

    granted

  15. US 7491798

    Scytovirins and related conjugates, fusion proteins, nucleic acids, vectors, host cells, compositions, antibodies and methods of using scytovirins

    The United States of America, as represented by the Department of Health and Human Services · Granted Feb 17, 2009 · Expires Feb 12, 2029

    granted

  16. US 7488710

    SFRP and peptide motifs that interact with SFRP and methods of their use

    The United States of America, as represented by the Department of Health and Human Services · Granted Feb 10, 2009 · Expires Feb 5, 2029

    granted

  17. US 7485415

    Sequence analysis of the tetravalent rotavirus vaccine

    The United States of America, as represented by the Department of Health and Human Services · Granted Feb 3, 2009 · Expires Jan 29, 2029

    granted

  18. US 7485440

    Production of attenuated respiratory syncytial virus vaccines involving modification of M2 ORF2

    The United States of America, as represented by the Department of Health and Human Services · Granted Feb 3, 2009 · Expires Jan 29, 2029

    granted

  19. US 7479280

    Virus-like particles for the induction of autoantibodies

    The United States of America, as represented by the Department of Health and Human Services · Granted Jan 20, 2009 · Expires Jan 15, 2029

    granted

  20. US 7476535

    TRP2 isoform TRP2-6b containing HLA-A2 restricted epitopes

    The United States of America, as represented by the Department of Health and Human Services · Granted Jan 13, 2009 · Expires Jan 8, 2029

    granted

  21. US 7470430

    Modifications of HIV, ENV, GAG, and POL enhance immunogenicity for genetic immunization

    The United States of America, as represented by the Department of Health and Human Services · Granted Dec 30, 2008 · Expires Dec 25, 2028

    granted

  22. US 7470506

    Fitness assay and associated methods

    The United States of America, as represented by the Department of Health and Human Services · Granted Dec 30, 2008 · Expires Dec 25, 2028

    granted

  23. US 7470775

    Anti-CD30 stalk and anti-CD30 antibodies suitable for use in immunotoxins

    The United States of America, as represented by the Department of Health and Human Services · Granted Dec 30, 2008 · Expires Dec 25, 2028

    granted

  24. US 7468352

    Mutated anthrax toxin protective antigen proteins that specifically target cells containing high amounts of cell-surface metalloproteinases or plasminogen activator receptors

    The United States of America, as represented by the Department of Health and Human Services · Granted Dec 23, 2008 · Expires Dec 18, 2028

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.